ANJALI NEMAWARKAR: Open Payments
NPI 1093779555 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 39 payments from 15 companies in 2025. Trend: 2023 $472 · 2024 $942 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
| Novo Nordisk Inc | 4 | $97 |
| Astellas Pharma US Inc | 4 | $89 |
| Exact Sciences Corporation | 4 | $88 |
| Biogen, Inc. | 3 | $82 |
| Verona Pharma, Inc. | 2 | $54 |
| Amgen Inc. | 3 | $47 |
| Lilly USA, LLC | 3 | $45 |
Products named: VOQUEZNA, Veozah, Cologuard Collection Kit, LEQEMBI, VYNDAQEL, Ohtuvayre, EVENITY, MOUNJARO.
Industry payments across TX — which companies pay providers there.
